4.6 Review

Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology

Journal

MOLECULES
Volume 27, Issue 15, Pages -

Publisher

MDPI
DOI: 10.3390/molecules27154839

Keywords

Alzheimer's disease; gene therapy; pathophysiology; nanomedicines; phytopharmaceuticals; neurofibrillary tangles; nutraceuticals

Funding

  1. Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia [IFP2021-095]

Ask authors/readers for more resources

Alzheimer's disease is a chronic dysfunction of neurons in the brain that leads to dementia. It is characterized by gradual mental decline, abnormal cognitive functioning, personality changes, diminished verbal fluency, and speech impairment. While there is no cure for AD, its progression can be delayed using FDA-approved drugs. An extensive literature survey and clinical trials have been conducted to explore various strategies for preventing the disease.
Alzheimer's disease (AD) is a chronic dysfunction of neurons in the brain leading to dementia. It is characterized by gradual mental failure, abnormal cognitive functioning, personality changes, diminished verbal fluency, and speech impairment. It is caused by neuronal injury in the cerebral cortex and hippocampal area of the brain. The number of individuals with AD is growing at a quick rate. The pathology behind AD is the progress of intraneuronal fibrillary tangles, accumulation of amyloid plaque, loss of cholinergic neurons, and decrease in choline acetyltransferase. Unfortunately, AD cannot be cured, but its progression can be delayed. Various FDA-approved inhibitors of cholinesterase enzyme such as rivastigmine, galantamine, donepezil, and NDMA receptor inhibitors (memantine), are available to manage the symptoms of AD. An exhaustive literature survey was carried out using SciFinder's reports from Alzheimer's Association, PubMed, and Clinical Trials.org. The literature was explored thoroughly to obtain information on the various available strategies to prevent AD. In the context of the present scenario, several strategies are being tried including the clinical trials for the treatment of AD. We have discussed pathophysiology, various targets, FDA-approved drugs, and various drugs in clinical trials against AD. The goal of this study is to shed light on current developments and treatment options, utilizing phytopharmaceuticals, nanomedicines, nutraceuticals, and gene therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available